Virtual screening of flavonoids as potential RIPK1 inhibitors for neurodegeneration therapy.
Asim Kumar BepariSwakkhar ShatabdaHasan Mahmud RezaPublished in: PeerJ (2024)
studies with these ligands could offer new hope for developing effective therapeutics and improving the quality of life for individuals affected by neurodegeneration.